Pages
Products
AAV9-CaMKII-GCaMP6m

AAV9-CaMKII-GCaMP6m

Cat.No. :  AAV00280Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 9 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00280Z
Description AAV serotype 9 particles contain calcium indicator GCaMP6m under CaMKII promoter.
Serotype AAV Serotype 9
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

AAV, first discovered in adenoviral preparations more than 50 years ago, is a helper-dependent, single-stranded DNA virus belonging to the family Parvoviridae. AAV infection of cells begins with the binding of the viral capsid to cell surface receptors. Subsequently, AAV enters the cell via multiple pathways and subsequently sorts into endosomal and Golgi compartments. AAV particles then escape into the cytoplasm, accumulate around the perinuclear space, and eventually enter the nucleus for genome release and replication. The AAV genome contains coding sequences for the rep (replication), cap (capsid), and aap [assembly activation protein (AAP)] genes. The proteins encoded by rep are required for genome replication and packaging, while proteins constituting the capsid are produced by the cap gene. AAP is required for capsid assembly in certain serotypes. The viral genome is flanked by inverted terminal repeats (ITRs), which are unique recognition sequences required for genome encapsidation and serve as the origin of genome replication. Viral replication and production of viral progeny is only possible in the presence of helper functions provided by repeated infection with other viruses such as adenovirus or herpesvirus. In the absence of auxiliary functions, latency can be established.

Ischemic stroke is one of the leading causes of adult disability, morbidity, and death worldwide. After stroke, acute neuronal excitotoxicity leads to many deleterious consequences, one of which is intracellular calcium dysregulation, ultimately leading to cell death. Using the fluorescent calcium indicator GCaMP, researchers tracked neuronal population response in freely moving animals immediately following distal middle cerebral artery occlusion (dMCAO) in both the core infarct and peri-infarct regions. The results showed that calcium excitotoxicity after arterial occlusion can generally be divided into two phases: a transient increase in activity lasting tens of minutes, followed by a longer, slower, and sustained increase in the fluorescent signal. The first phase is primarily thought to represent neuronal hyperexcitability, defining the therapeutic window, while the second phase may represent gradual cell death. Importantly, the study found that the level of intracellular calcium following artery occlusion correlated with the infarct size at 24 h demonstrating a direct connection between excitotoxicity and cell death in our stroke model. Furthermore, administration of the NMDA antagonist MK-801 resulted in a reduction in calcium signaling and subsequent reduction in infarct size.

To record intracellular calcium in pyramidal neurons, researchers performed stereotaxic viral injections of GCaMP6m (AAV9-CaMKII-GCaMP6m) and then implanted an optical fiber above the injection site (Figure 1A, top). The initial recording location was chosen based on calibration experiments in the distal middle cerebral artery occlusion model (dMCAO), which showed that this area of the cortex was located in the infarct center. After 2-3 weeks of recovery, the second phase (Figure 1A, middle) included the recording day. Briefly, after baseline photometric recordings, mice were injected with vehicle or MK-801. After 15 minutes, mice were taken to the dMCAO operating room, and recordings continued for the next 3 hours. After 24 hours, in the third phase (Figure 1A, bottom), TTC staining was performed on serial brain sections. The infarct was fully formed in the dMCAO model at the 24-hour time point.

At 24 h following artery occlusion, the volume of the infarct tissue extended to 7 mm from rostral to caudal and covered most of the somatosensory cortex (Figure 1B). Interestingly, the researchers found that the overall infarct size was significantly larger in CRLC57 mice compared to the JaxC57 substrain (Figure 1C). Investigating the infarcted tissue section by section, the data showed that although the infarct size was significantly larger in CRLC57 mice from rostral to caudal, no interaction between mouse substrain and section position was found by two-way ANOVA (Figure 1D). These results indicate that despite the overall differences in the size of the infarct tissue between the different mouse substrains, the infarct core (located in both groups in section 3) and the pattern of tissue damage were similar between the groups.

Experimental paradigm for fiber photometry recordings in freely moving mice immediately following permanent distal middle cerebral artery occlusion.Figure 1. Experimental paradigm for fiber photometry recordings in freely moving mice immediately following permanent distal middle cerebral artery occlusion. (Nelson A N, et al., 2020)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reliable Performance

The AAV9-CaMKII-GCaMP6m product is simply outstanding. It delivered consistent and repeatable results across multiple experiments, allowing us to observe neuronal calcium dynamics with high temporal resolution.

United States

01/05/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction